Contributor Page
Gilbertís LLP
 
Email  |  Articles
Contact Details
Fax: +1 416 703 7422
The Flatiron Building
49 Wellington Street East
Toronto
M5E 1C9
Canada
By Sundeep Chauhan
Every year on March 31 Canadian Collective Societies (Collectives) file tariff proposals with the Copyright Board of Canada. These tariff proposals set out what the Collectives believe businesses should pay for the use of music, audio-visual works (e.g. movies) and literary works (e.g. books).
By Sundeep Chauhan
Every year on March 31 Canadian Collective Societies (Collectives) file tariff proposals with the Copyright Board of Canada. These tariff proposals set out what the Collectives believe businesses should pay for the use of music, audio-visual works (e.g. movies) and literary works (e.g. books).
By Sundeep Chauhan
Every year on March 31 Canadian Collective Societies (Collectives) file tariff proposals with the Copyright Board of Canada.
By Sundeep Chauhan
Every year on March 31 Canadian Collective Societies (Collectives) file tariff proposals with the Copyright Board of Canada.
By Sundeep Chauhan
On June 2, 2010 the Federal Government tabled Bill C-32: the Copyright Modernization Act in Parliament (Bill C-32). Bill C-32 represents a comprehensive set of amendments to the Copyright Act (the "Act").
By Sana Halwani
On August 3, 2010, the Federal Court released reasons in "Novo Nordisk Canada Inc. et al. v. Cobalt Pharmaceuticals Inc. et al." (2010 FC 746; "Novo Nordisk")) finding Cobaltís allegation of obviousness justified with respect to Canadian Patent No. 2,111,851. The patent covers repaglinide (an (S) enantiomer), its use for the treatment of Type 2 Diabetes, and processes to make it.
By Alexander Stack
Canada and the European Union (EU) are negotiating an intellectual property (IP) agreement, as part of a broader free trade agreement, which may have great impact in the pharmaceutical and related industries.
By Nathaniel Lipkus, Shonagh McVean
Patent prosecution in Canada is often managed from abroad and typically takes a back seat to prosecution of corresponding patents in larger markets, such as the US and Europe.